{
"name": "Aktis Oncology, Inc.",
"legal_name": "Aktis Oncology, Inc.",
"ticker": "AKTS",
"tickers": [
"AKTS"
],
"cik": "0002035832",
"page_url": "https://steadybase.io/company/aktis-oncology-inc/",
"markdown_url": "https://steadybase.io/company/aktis-oncology-inc.md",
"json_url": "https://steadybase.io/company/aktis-oncology-inc.json",
"as_of": "2026-11-10",
"last_filed": "2026-08-13",
"industry": {
"sic": "2834",
"description": "Pharmaceutical Preparations"
},
"headquarters": {
"city": "Boston",
"state": "MA",
"country": "US"
},
"exchanges": [
"Nasdaq"
],
"fiscal_year_end": "December 31",
"filer_category": "Non-accelerated filer
Smaller reporting company
Emerging growth company",
"state_of_incorporation": "DE",
"website": "aktisoncology.com",
"investor_relations_url": null,
"linkedin_company_url": "https://www.linkedin.com/company/aktis-oncology",
"summary": {
"text": "We are a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large patient populations, including those not addressed by existing platform technologies. The field of targeted radiopharmaceuticals is currently led by two marketed products that illustrated transformative survival outcomes and quality of life benefits can be conferred by delivering radioisotopes to solid tumors.",
"section": "Item 1. Business",
"period_end": "2025-12-31",
"source_url": "https://www.sec.gov/Archives/edgar/data/2035832/000119312526131748/aktis_12.31.25_10k.htm"
},
"key_facts": [
{
"key": "employees",
"label": "Employees",
"value": 79,
"unit": "people",
"period_end": "2025-12-31",
"source_url": "https://www.sec.gov/Archives/edgar/data/2035832/000119312526131748/aktis_12.31.25_10k.htm",
"text": "Employees: 79 as of Dec 31, 2025, as reported in an SEC filing."
}
],
"metrics": {},
"next_earnings": {
"date": "2026-11-12",
"confidence": "medium",
"webcast_url": null
},
"people": [
{
"name": "Matthew Roden, PhD",
"title": "President and Chief Executive Officer",
"role": "both",
"linkedin_url": null,
"form": "10-K",
"filed": "2026-03-30",
"source_url": "https://www.sec.gov/Archives/edgar/data/2035832/000119312526131748/aktis_12.31.25_10k.htm"
},
{
"name": "Matthew Roden",
"title": "President and CEO",
"role": "both",
"linkedin_url": "https://linkedin.com/in/matthew-roden-26499a43",
"form": "3",
"filed": "2026-01-08",
"source_url": "https://www.sec.gov/Archives/edgar/data/2035832/000119312526008065/0001193125-26-008065-index.htm"
},
{
"name": "Kyle D. Kuvalanka",
"title": "Chief Financial Officer",
"role": "officer",
"linkedin_url": "https://linkedin.com/in/kyle-kuvalanka-960a592b",
"form": "10-K",
"filed": "2026-03-30",
"source_url": "https://www.sec.gov/Archives/edgar/data/2035832/000119312526131748/aktis_12.31.25_10k.htm"
},
{
"name": "Shulamit Ron-Bigger",
"title": "Chief Operating Officer",
"role": "officer",
"linkedin_url": "https://linkedin.com/in/shulamit-ron-bigger-2047172b",
"form": "4",
"filed": "2026-07-10",
"source_url": "https://www.sec.gov/Archives/edgar/data/2035832/000119312526300163/0001193125-26-300163-index.htm"
},
{
"name": "Shulamit Ron-Bigger, PhD",
"title": "Chief Operating Officer",
"role": "officer",
"linkedin_url": null,
"form": "10-K",
"filed": "2026-03-30",
"source_url": "https://www.sec.gov/Archives/edgar/data/2035832/000119312526131748/aktis_12.31.25_10k.htm"
},
{
"name": "Akos Czibere",
"title": "Chief Medical Officer",
"role": "officer",
"linkedin_url": null,
"form": "4",
"filed": "2026-09-24",
"source_url": "https://www.sec.gov/Archives/edgar/data/2035832/000119312526401014/0001193125-26-401014-index.htm"
},
{
"name": "Akos Czibere, MD, PhD",
"title": "Chief Medical Officer",
"role": "officer",
"linkedin_url": null,
"form": "10-K",
"filed": "2026-03-30",
"source_url": "https://www.sec.gov/Archives/edgar/data/2035832/000119312526131748/aktis_12.31.25_10k.htm"
},
{
"name": "Paul L. Feldman, PhD",
"title": "Chief Scientific Officer",
"role": "officer",
"linkedin_url": null,
"form": "10-K",
"filed": "2026-03-30",
"source_url": "https://www.sec.gov/Archives/edgar/data/2035832/000119312526131748/aktis_12.31.25_10k.htm"
},
{
"name": "Tyler Benedum, PhD",
"title": "Chief Technical Officer",
"role": "officer",
"linkedin_url": null,
"form": "10-K",
"filed": "2026-03-30",
"source_url": "https://www.sec.gov/Archives/edgar/data/2035832/000119312526131748/aktis_12.31.25_10k.htm"
},
{
"name": "Paul L. Feldman",
"title": "Chief Scientific Officer",
"role": "officer",
"linkedin_url": "https://linkedin.com/in/paul-feldman-6022a2b7",
"form": "3",
"filed": "2026-01-08",
"source_url": "https://www.sec.gov/Archives/edgar/data/2035832/000119312526008060/0001193125-26-008060-index.htm"
},
{
"name": "Helen S. Kim, MBA",
"title": "Director",
"role": "director",
"linkedin_url": null,
"form": "10-K",
"filed": "2026-03-30",
"source_url": "https://www.sec.gov/Archives/edgar/data/2035832/000119312526131748/aktis_12.31.25_10k.htm"
},
{
"name": "Ken Herrmann, MD",
"title": "Director",
"role": "director",
"linkedin_url": null,
"form": "10-K",
"filed": "2026-03-30",
"source_url": "https://www.sec.gov/Archives/edgar/data/2035832/000119312526131748/aktis_12.31.25_10k.htm"
}
],
"events_8k": [
{
"filed": "2026-08-13",
"items": [
{
"item": "2.02",
"label": "Results of operations and financial condition (earnings release)",
"signal": "earnings"
},
{
"item": "9.01",
"label": "Financial statements and exhibits",
"signal": "exhibits"
}
],
"source_url": "https://www.sec.gov/Archives/edgar/data/2035832/000119312526349133/ck0002035832-20260813.htm"
},
{
"filed": "2026-05-11",
"items": [
{
"item": "2.02",
"label": "Results of operations and financial condition (earnings release)",
"signal": "earnings"
},
{
"item": "9.01",
"label": "Financial statements and exhibits",
"signal": "exhibits"
}
],
"source_url": "https://www.sec.gov/Archives/edgar/data/2035832/000119312526216716/ck0002035832-20260511.htm"
},
{
"filed": "2026-04-16",
"items": [
{
"item": "5.02",
"label": "Departure or appointment of directors or officers; compensation",
"signal": "leadership_change"
},
{
"item": "7.01",
"label": "Regulation FD disclosure",
"signal": "disclosure"
},
{
"item": "9.01",
"label": "Financial statements and exhibits",
"signal": "exhibits"
}
],
"source_url": "https://www.sec.gov/Archives/edgar/data/2035832/000119312526158944/d110479d8k.htm"
},
{
"filed": "2026-03-30",
"items": [
{
"item": "2.02",
"label": "Results of operations and financial condition (earnings release)",
"signal": "earnings"
},
{
"item": "9.01",
"label": "Financial statements and exhibits",
"signal": "exhibits"
}
],
"source_url": "https://www.sec.gov/Archives/edgar/data/2035832/000119312526132524/ck0002035832-20260330.htm"
},
{
"filed": "2026-01-12",
"items": [
{
"item": "5.03",
"label": "Amendments to articles or bylaws; change in fiscal year",
"signal": "governance"
},
{
"item": "9.01",
"label": "Financial statements and exhibits",
"signal": "exhibits"
}
],
"source_url": "https://www.sec.gov/Archives/edgar/data/2035832/000119312526010354/d932945d8k.htm"
}
],
"insider_trades": [
{
"owner": "Akos Czibere",
"role": "Chief Medical Officer",
"action": "sold",
"code": "S",
"shares": 12500,
"value_usd": 258592,
"date": "2026-09-23",
"filed": "2026-09-24",
"source_url": "https://www.sec.gov/Archives/edgar/data/2035832/000119312526401014/0001193125-26-401014-index.htm"
},
{
"owner": "Ken Herrmann",
"role": "Director",
"action": "sold",
"code": "S",
"shares": 4856,
"value_usd": 119263,
"date": "2026-07-20",
"filed": "2026-07-21",
"source_url": "https://www.sec.gov/Archives/edgar/data/2035832/000119312526310991/0001193125-26-310991-index.htm"
},
{
"owner": "Ken Herrmann",
"role": "Director",
"action": "sold",
"code": "S",
"shares": 3065,
"value_usd": 77269,
"date": "2026-07-17",
"filed": "2026-07-20",
"source_url": "https://www.sec.gov/Archives/edgar/data/2035832/000119312526309115/0001193125-26-309115-index.htm"
},
{
"owner": "Shulamit Ron-Bigger",
"role": "Chief Operating Officer",
"action": "sold",
"code": "S",
"shares": 50000,
"value_usd": 1387604,
"date": "2026-07-08",
"filed": "2026-07-10",
"source_url": "https://www.sec.gov/Archives/edgar/data/2035832/000119312526300163/0001193125-26-300163-index.htm"
},
{
"owner": "Akos Czibere",
"role": "Chief Medical Officer",
"action": "sold",
"code": "S",
"shares": 50000,
"value_usd": 1388686,
"date": "2026-07-08",
"filed": "2026-07-10",
"source_url": "https://www.sec.gov/Archives/edgar/data/2035832/000119312526300162/0001193125-26-300162-index.htm"
},
{
"owner": "Todd Foley",
"role": "Director",
"action": "bought",
"code": "P",
"shares": 232870,
"value_usd": 4191660,
"date": "2026-01-12",
"filed": "2026-01-14",
"source_url": "https://www.sec.gov/Archives/edgar/data/2035832/000147393026000005/0001473930-26-000005-index.htm"
},
{
"owner": "Helen Susan Kim",
"role": "Director",
"action": "bought",
"code": "P",
"shares": 835000,
"value_usd": 15030000,
"date": "2026-01-12",
"filed": "2026-01-12",
"source_url": "https://www.sec.gov/Archives/edgar/data/2035832/000119312526010566/0001193125-26-010566-index.htm"
},
{
"owner": "Oleg Nodelman",
"role": "Director",
"action": "bought",
"code": "P",
"shares": 2222222,
"value_usd": 39999996,
"date": "2026-01-12",
"filed": "2026-01-12",
"source_url": "https://www.sec.gov/Archives/edgar/data/2035832/000093583626000031/0000935836-26-000031-index.htm"
},
{
"owner": "Capital LLC EcoR1",
"role": "Director",
"action": "bought",
"code": "P",
"shares": 2222222,
"value_usd": 39999996,
"date": "2026-01-12",
"filed": "2026-01-12",
"source_url": "https://www.sec.gov/Archives/edgar/data/2035832/000093583626000031/0000935836-26-000031-index.htm"
}
],
"quotes": [],
"latest_filings": [
{
"form": "8-K",
"filed": "2026-08-13",
"source_url": "https://www.sec.gov/Archives/edgar/data/2035832/000119312526349133/ck0002035832-20260813.htm"
},
{
"form": "10-K",
"filed": "2026-03-30",
"source_url": "https://www.sec.gov/Archives/edgar/data/2035832/000119312526131748/aktis_12.31.25_10k.htm"
},
{
"form": "10-Q",
"filed": "2026-08-13",
"source_url": "https://www.sec.gov/Archives/edgar/data/2035832/000119312526349144/ck0002035832-20260630.htm"
}
],
"source": "SEC EDGAR filings, read by Steadybase. Every value links to the filing it came from."
}